AbCellera Partners With Eli Lilly to Create COVID-19 Treatment
They hope to advance a therapy into FDA clinical trials this summer…
They hope to advance a therapy into FDA clinical trials this summer…
Moderna got FDA permission to skip the animal trials that are typically required before a therapy can be tested...
One of the most challenging tasks humanity will face over the next few years is to use bleeding-edge technology...
The 5G build-out has not slowed down in the slightest…
Thanks to the COVID-19 outbreak, consumers are now using Amazon more than ever before…
If a Foldit player can “crack the code” and design the right protein structure, it could be used to...
The work DeepMind has been doing on COVID-19 revolves around analyzing protein structures…
This could give everyday investors several opportunities to invest in private technology companies while they are just getting off...
The goal is to move to 100% biometric IDs by 2022 – less than two years from now. Physical...
Thanks for signing up for The Bleeding Edge — we’re glad you’re here!
Want updates sent straight to your phone too? Sign up for SMS alerts to get the latest delivered via text.
Brownstone Research: By submitting your phone number, you agree to our SMS Terms & Conditions, Terms of Use, & Privacy Policy, and give express written consent to receive marketing text messages from BSR. Messages are recurring & frequency may vary. Reply STOP to 94703 to opt out. Reply HELP to 94703 for info. Consent is not a condition of purchase. Message and data rates may apply. For additional information, you may contact Customer Service at 888-512-0726 or smssupport@brownstoneresearch.com.